Mylan Pharmaceuticals, Inc. v. American Safety Razor Co.

265 F. Supp. 2d 635, 2002 U.S. Dist. LEXIS 26397, 2002 WL 32105205
CourtDistrict Court, N.D. West Virginia
DecidedDecember 12, 2002
Docket1:02CV88
StatusPublished
Cited by2 cases

This text of 265 F. Supp. 2d 635 (Mylan Pharmaceuticals, Inc. v. American Safety Razor Co.) is published on Counsel Stack Legal Research, covering District Court, N.D. West Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mylan Pharmaceuticals, Inc. v. American Safety Razor Co., 265 F. Supp. 2d 635, 2002 U.S. Dist. LEXIS 26397, 2002 WL 32105205 (N.D.W. Va. 2002).

Opinion

ORDER DENYING DEFENDANT INTERNATIONAL PAPER’S MOTION TO DISMISS OR TRANSFER

KEELEY, Chief Judge.

This matter comes before the Court on Defendant International Paper Company’s Motion to Dismiss or Transfer. The motion is fully briefed and ripe for review. For the reasons that follow, the Court DENIES the motion.

Background.

Plaintiff Mylan Pharmaceuticals, Inc. (Mylan) bought 10 lots of defective pill-bottle cotton balls from Defendant American Safety Razor Company (ASR), which supplied the cotton through its division, Megas Beauty Care d/b/a Personna Medical (Personna). Personna obtained the cotton from Defendant International Paper Company (IP) through its Veratec division. In July 1998, IP sold Veratec to Defendants BBA Nonwovens Simpsonville and BBA U.S. Holdings (together, BBA Non-wovens), thus making BBA Nonwovens Personna’s new cotton supplier (via Vera-tec).

The complaint alleges that, in mid-1998, Personna requested that Veratec treat its cotton with extra hydrogen peroxide. Per-sonna then used some of this treated cotton to fill Mylan’s orders. Allegedly, the treatment made the cotton unfit for pharmaceutical use. In early March 1999, Per-sonna finally informed Mylan that specific lots of cotton had been treated with the hydrogen peroxide and that Mylan should act accordingly. Mylan investigated and discovered that much of the affected cotton had already been' used in pill bottles and had damaged the drugs inside.

Mylan now seeks damages for the defective cotton, asserting that all the Defendants knew about its needs and therefore breached actual or implied contracts.

BBA Nonwovens has asserted cross claims for indemnification and contribution against ASR, Personna, and IP. ASR has asserted cross claims for indemnification and contribution against BBA Nonwovens and IP. Personna has asserted cross claims for indemnification and contribution against BBA Nonwovens and IP. IP has asserted cross claims for indemnification and contribution against ASR and Person-na; IP has carefully avoided asserting any cross claims against BBA Nonwovens.

IP now moves to dismiss BBA Nonwov-ens’ cross claim against it, or, alternatively, to transfer the claim to the Southern District of New York. IP bases its motion entirely upon the presence of a forum selection clause contained in an Amended and Restated Purchase Agreement entered into in April 1998 between IP and the BBA Nonwovens entities. The Forum selection clause in the Amended and Restated Purchase Agreement states:

Seller and each Member of Buyer Group (a) agree that any suit, action or proceeding arising out of or relating to this Agreement shall be brought solely in the state or federal courts of New York; (b) consents to the exclusive jurisdiction of each such court in any suit, action or proceeding relating to or arising out of this Agreement; (c) waives any objection which it may have to the laying of venue in any such suit, action or proceeding in any such court; and (d) agrees that service of any court paper may be made in such manner as may be provided under applicable laws or court rules governing service of process.
*638 This Agreement will be governed by, and construed and enforced in accordance with, the laws of the State of New York (regardless of the laws that might otherwise govern under applicable principles of conflicts of laws thereof) as to all matters, including but not limited to matters of validity, construction, effect, performance and remedies.

The parties do not contest the validity of the forum selection clause.

Motion to Dismiss.

IP facially brings its motion to dismiss under Federal Rules of Civil Procedure 12(b)(1), 12(b)(2), 12(b)(8), and 12(b)(6). However, IP does not structure its argument under any of these sections, but rather makes the assumption that the Court should simply enforce a valid forum selection clause and dismiss the cross claim.

This approach does not rest well with the Supreme Court’s ruling in Stewart v. Ricoh Corp., 487 U.S. 22, 29, 108 S.Ct. 2239, 101 L.Ed.2d 22 (1988) (holding that motions to transfer based on a forum selection clause are to be dealt with under standards established by Congress in 28 U.S,C. § 1404, with the forum selection clause receiving its proper, but not controlling, weight in the statutory factor analysis). While academics continue to debate the proper vehicle for effectuating forum selection clauses, see Silva v. Encyclopedia Britannica, Inc., 239 F.3d 385, 388 n. 3 (1st Cir.2001) (outlining debate), the parties have not raised this issue, and the Court concludes that the best approach in this case is that touched upon in M/S Bremen v. Zapata Off-Shore Co., 407 U.S. 1, 92 S.Ct. 1907, 32 L.Ed.2d 513 (1972):

The argument that such clauses are improper because they tend to “oust” a court of jurisdiction is hardly more than a vestigial legal fiction. It appears to rest at core on historical judicial resistance to any attempt to reduce the power and business of a particular court and has little place in an era when all courts are overloaded and when businesses once essentially local now operate in world markets. It reflects something of a provincial attitude regarding the fairness of other tribunals. No one seriously contends in this case that the forum selection clause “ousted” the District Court of jurisdiction over Zapata’s action. The threshold question is whether that court should have exercised its jurisdiction to do more than give effect to the legitimate expectations of the parties, manifested in their freely negotiated agreement, by specifically enforcing the forum clause.

407 U.S. at 12, 92 S.Ct. 1907 (emphasis added). Thus, the presence of a forum selection clause allows the district court to decline the exercise of jurisdiction it otherwise possesses.

Forum selection clauses are presumptively enforceable absent a strong showing that the clause should be set aside or not enforced because the circumstances would render it “unreasonable.” M/S Bremen, 407 U.S. 1, 92 S.Ct. 1907 (establishing rule). Forum selection clauses can be unreasonable where there is a possibility of prejudice to the parties through conflicting judgments by the concurrent litigation in two courts, or when forcing them to refile subordinate claims in a separate court would be a gross waste of the parties’ and the court’s resources. See Taylor Investment Corp. v. Weil, 169 F.Supp.2d 1046, 1061 (D.Minn.2001); Ace Novelty, Inc. v. Vijuk Equip., Inc., 1991 WL 150191, at *7 (N.D.Ill. July 31,1991).

IP argues that the forum selection clause sub judice was entered into fairly, is valid, and that enforcement is reasonable.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McNair v. Monsanto Co.
279 F. Supp. 2d 1290 (M.D. Georgia, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
265 F. Supp. 2d 635, 2002 U.S. Dist. LEXIS 26397, 2002 WL 32105205, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mylan-pharmaceuticals-inc-v-american-safety-razor-co-wvnd-2002.